Bristol-Myers Squibb Company Ce (CELG-RI)
NYQ
$0.08-0.04 (-31.10%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
$0.08–$0.12
Beta
—
Company overview
No company overview is available for Bristol-Myers Squibb Company Ce yet.
Peers in industry
Bristol-Myers Squibb Company Ce has no peer companies in this window.
Recent press releases
Bristol-Myers Squibb Company Ce has not issued a press release in this window.
SEC filings
All filings →Bristol-Myers Squibb Company Ce has not filed an SEC document in this window.
Insider trades
All insider trades →Bristol-Myers Squibb Company Ce has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
VANGUARD GROUP INC$10.72B
198,727,768 sh+1.4%
BlackRock, Inc.$9.54B
176,825,406 sh+0.7%
25,796,905 sh+172.6%
STATE STREET CORP$5.29B
97,980,438 sh+1.4%
Royal Bank of Canada$683.4M
12,668,885 sh-54.0%
52,638,346 sh+13.1%
24,495,875 sh+47.0%
71,322,392 sh-2.4%
People at Bristol-Myers Squibb Company Ce
All people →No officers or directors have been indexed for Bristol-Myers Squibb Company Ce.
Quarterly financials
Full financials →Revenue trend
03/25
$403.0M
NI $2.46B
06/25
$568.0M
NI $1.31B
09/25
$12.22B
NI $2.20B
RevenueNI = Net Income
EPS trend (diluted)
Latest: $1.08
Prior: $0.64
Revenue sparkline